Addex Therapeutics (ADXN) Short Interest Ratio & Short Volume → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free ADXN Stock Alerts $9.00 -0.20 (-2.17%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Addex Therapeutics Short Interest DataCurrent Short Interest5,500 sharesPrevious Short Interest14,700 sharesChange Vs. Previous Month-62.59%Dollar Volume Sold Short$49,500.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,060,000 sharesFloat Size793,400 sharesShort Percent of Float0.69%Today's Trading Volume4,300 sharesAverage Trading Volume4,113 sharesToday's Volume Vs. Average105% Short Selling Addex Therapeutics ? Sign up to receive the latest short interest report for Addex Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADXN Short Interest Over TimeADXN Days to Cover Over TimeADXN Percentage of Float Shorted Over Time Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Addex Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20245,500 shares $49,500.00 -62.6%0.7%0.3 $9.00 4/30/202414,700 shares $112,455.00 -32.3%1.9%0.8 $7.65 4/15/202421,700 shares $537,075.00 +149.4%2.7%1.3 $24.75 3/31/20248,700 shares $111,360.00 -26.9%0.9%0.5 $12.80 3/15/202411,900 shares $139,349.00 +41.7%1.2%1.2 $11.71 2/29/20248,400 shares $79,884.00 +33.3%0.8%0.9 $9.51 Get the Latest News and Ratings for ADXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,300 shares $66,087.00 -27.6%0.6%0.7 $10.49 1/31/20248,700 shares $94,308.00 +222.2%0.9%0.8 $10.84 1/15/20242,700 shares $18,765.00 +12.5%0.3%0.3 $6.95 12/31/20232,400 shares $14,520.00 -33.3%0.2%0.2 $6.05 12/15/20233,600 shares $19,548.00 -14.3%0.4%0.4 $5.43 11/30/20234,200 shares $23,310.00 -25.0%0.5%0.5 $5.55 11/15/20235,600 shares $34,160.00 +5.7%0.8%0.8 $6.10 10/31/20235,300 shares $33,337.00 No Change0.8%1 $6.29 10/15/20235,300 shares $43,036.00 -95.4%N/A1.3 $8.12 9/30/2023115,900 shares $44,540.37 -35.0%N/A1.7 $0.38 9/15/2023178,200 shares $74,844.00 +76.1%N/A3.3 $0.42 8/31/2023101,200 shares $46,248.40 -8.9%N/A2 $0.46 8/15/2023111,100 shares $59,216.30 -4.4%N/A1.7 $0.53 7/31/2023116,200 shares $65,072.00 -16.6%N/A0.3 $0.56 7/15/2023139,400 shares $82,106.60 -13.6%N/A0.4 $0.59 6/30/2023161,300 shares $84,037.30 -28.7%N/A0.4 $0.52 6/15/2023226,300 shares $149,358.00 -40.4%3.0%0.5 $0.66 5/31/2023379,900 shares $246,593.09 -43.6%5.1%0.7 $0.65 5/15/2023673,100 shares $567,086.75 +358.5%9.0%1.2 $0.84 4/30/2023146,800 shares $104,183.96 -34.2%N/A0.4 $0.71 4/15/2023223,100 shares $172,980.59 +195.9%N/A0.5 $0.78 3/31/202375,400 shares $71,343.48 -7.6%N/A0.2 $0.95 3/15/202381,600 shares $89,760.00 -75.9%N/A0.3 $1.10 2/28/2023338,700 shares $694,335.00 +149.8%N/A1.1 $2.05 2/15/2023135,600 shares $203,400.00 -55.2%N/A0.5 $1.50 1/31/2023302,400 shares $323,568.00 +484.9%N/A1.3 $1.07 1/15/202351,700 shares $44,979.00 +28.0%N/A0.3 $0.87 12/30/202240,400 shares $25,456.08 +15.8%0.5%0.3 $0.63 12/15/202234,900 shares $21,149.40 -25.3%0.9%0.3 $0.61 11/30/202246,700 shares $35,954.33 -57.4%1.6%0.3 $0.77 11/15/2022109,700 shares $89,416.47 +247.2%3.6%0.7 $0.82 10/31/202231,600 shares $26,860.00 -41.6%0.6%0.2 $0.85 10/15/202254,100 shares $43,280.00 -43.1%0.9%0.2 $0.80 9/30/202295,100 shares $76,060.98 +37.0%1.7%0 $0.80It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 9/15/202269,400 shares $66,624.00 -46.7%1.2%0 $0.96 8/31/2022130,300 shares $140,724.00 -11.2%2.3%0 $1.08 8/15/2022146,800 shares $204,052.00 -30.0%2.6%0.1 $1.39 7/31/2022209,800 shares $242,885.46 +11,555.6%3.4%0.1 $1.16 7/15/20221,800 shares $1,781.46 -71.9%0.0%0 $0.99 6/30/20226,400 shares $7,360.00 +106.5%0.1%0.2 $1.15 6/15/20223,100 shares $10,571.00 +29.2%0.1%0.1 $3.41 5/31/20222,400 shares $9,048.00 +2,300.0%0.0%0.5 $3.77 5/15/2022100 shares $417.00 -80.0%N/A0 $4.17 4/30/2022500 shares $2,590.00 +25.0%N/A0.2 $5.18 4/15/2022400 shares $1,754.76 +300.0%N/A0.1 $4.39 3/31/2022100 shares $508.00 -50.0%N/A0 $5.08 3/15/2022200 shares $908.00 No ChangeN/A0.1 $4.54 2/28/2022200 shares $1,062.00 No ChangeN/A0 $5.31 2/15/2022200 shares $1,139.80 -93.3%N/A0 $5.70 1/31/20223,000 shares $17,190.00 +500.0%0.1%0.7 $5.73 1/15/2022500 shares $2,985.00 -96.4%0.0%0.1 $5.97 12/31/202113,800 shares $86,802.00 +885.7%0.3%4.3 $6.29 12/15/20211,400 shares $9,114.00 -12.5%0.0%0.5 $6.51 11/30/20211,600 shares $11,216.00 +6.7%0.0%0.8 $7.01 11/15/20211,500 shares $12,060.00 +87.5%0.0%0.8 $8.04 10/29/2021800 shares $6,312.00 -11.1%0.0%0.4 $7.89 10/15/2021900 shares $7,659.00 -25.0%0.0%0.4 $8.51 9/30/20211,200 shares $10,812.00 -63.6%0.0%0.3 $9.01 9/15/20213,300 shares $32,043.00 -13.2%0.1%0.8 $9.71 8/31/20213,800 shares $36,974.00 +111.1%0.1%0.8 $9.73 8/13/20211,800 shares $17,874.00 +157.1%0.0%0.4 $9.93 7/30/2021700 shares $6,895.00 -69.6%0.0%0.1 $9.85 7/15/20212,300 shares $22,195.00 +1,050.0%N/A0.4 $9.65 6/30/2021200 shares $1,912.00 -96.0%N/A0 $9.56 6/15/20215,000 shares $55,000.00 +354.6%N/A0.7 $11.00 5/28/20211,100 shares $10,285.11 -73.2%N/A0.2 $9.35 5/14/20214,100 shares $37,064.00 -43.1%N/A0.4 $9.04 4/30/20217,200 shares $71,928.00 +200.0%N/A0.4 $9.99 4/15/20212,400 shares $25,128.00 +140.0%N/A0.1 $10.47 3/31/20211,000 shares $10,400.00 -47.4%N/A0 $10.40 3/15/20211,900 shares $20,501.00 -71.2%N/A0 $10.79 2/26/20216,600 shares $74,580.00 +57.1%N/A0.1 $11.30 2/12/20214,200 shares $47,880.00 -67.9%N/A0 $11.40 1/29/202113,100 shares $144,755.00 +1,090.9%N/A0.1 $11.05 1/15/20211,100 shares $11,814.00 No ChangeN/A0 $10.74 ADXN Short Interest - Frequently Asked Questions What is Addex Therapeutics' current short interest? Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 5,500 shares of ADXN short. 0.69% of Addex Therapeutics' shares are currently sold short. Learn More on Addex Therapeutics' current short interest. What is a good short interest percentage for Addex Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.69% of Addex Therapeutics' floating shares are currently sold short. Is Addex Therapeutics' short interest increasing or decreasing? Addex Therapeutics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 5,500 shares, a decrease of 62.6% from the previous total of 14,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Addex Therapeutics' float size? Addex Therapeutics currently has issued a total of 1,060,000 shares. Some of Addex Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Addex Therapeutics currently has a public float of 793,400 shares. How does Addex Therapeutics' short interest compare to its competitors? 0.69% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Addex Therapeutics: VYNE Therapeutics Inc. (0.46%), Marker Therapeutics, Inc. (0.78%), ProMIS Neurosciences, Inc. (0.05%), Unicycive Therapeutics, Inc. (3.17%), Bolt Biotherapeutics, Inc. (8.82%), Spruce Biosciences, Inc. (0.30%), BioVie Inc. (1.79%), Enlivex Therapeutics Ltd. (1.10%), Acasti Pharma Inc. (0.02%), ImmunoPrecise Antibodies Ltd. (0.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Addex Therapeutics stock? Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. ADXN shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Addex Therapeutics? A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further. How often is Addex Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VYNE Short Interest Data MRKR Short Interest Data PMN Short Interest Data UNCY Short Interest Data BOLT Short Interest Data SPRB Short Interest Data BIVI Short Interest Data ENLV Short Interest Data ACST Short Interest Data IPA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADXN) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.